Janiszewska et al. [46] found that patients with MDS had a higher incidence of germline CHEK2 variants than healthy controls, and these patients also had a poorer prognosis than patients with MDS without CHEK2 alterations. Here, CHEK2 is linked to myelodysplastic syndrome.